Abstract:Myocardial damage is the most serious pathological consequence of cardiovascular diseases and an important reason for their high mortality. In recent years, because of the high prevalence of systemic energy metabolism disorders (e.g., obesity, diabetes mellitus, and metabolic syndrome), complications of myocardial damage caused by these disorders have attracted widespread attention. Energy metabolism disorders are independent of traditional injury-related risk factors, such as ischemia, hypoxia, trauma, and infection. An imbalance of myocardial metabolic flexibility and myocardial energy depletion are usually the initial changes of myocardial injury caused by energy metabolism disorders, and abnormal morphology and functional destruction of the mitochondria are their important features. Specifically, mitochondria are the centers of energy metabolism, and recent evidence has shown that decreased mitochondrial function, caused by an imbalance in mitochondrial quality control, may play a key role in myocardial injury caused by energy metabolism disorders. Under chronic energy stress, mitochondria undergo pathological fission, while mitophagy, mitochondrial fusion, and biogenesis are inhibited, and mitochondrial protein balance and transfer are disturbed, resulting in the accumulation of nonfunctional and damaged mitochondria. Consequently, damaged mitochondria lead to myocardial energy depletion and the accumulation of large amounts of reactive oxygen species, further aggravating the imbalance in mitochondrial quality control and forming a vicious cycle. In addition, impaired mitochondria coordinate calcium homeostasis imbalance, and epigenetic alterations participate in the pathogenesis of myocardial damage. These pathological changes induce rapid progression of myocardial damage, eventually leading to heart failure or sudden cardiac death. To intervene more specifically in the myocardial damage caused by metabolic disorders, we need to understand the specific role of mitochondria in this context in detail. Accordingly, promising therapeutic strategies have been proposed. We also summarize the existing therapeutic strategies to provide a reference for clinical treatment and developing new therapies.

Megamitochondria plasticity: function transition from adaption to disease

The role of mitochondrial dynamics in disease

Targeting Mitochondria: Influence of Metabolites on Mitochondrial Heterogeneity

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

Mitochondrial dynamics in health and disease: mechanisms and potential targets

Mitophagy, Mitochondrial Homeostasis, and Cell Fate

Mitochondria in health, disease, and aging

Mitochondria in disease: changes in shapes and dynamics

Mitochondrial heterogeneity in diseases

Mitochondria: It is all about energy

Giant mitochondria in cardiomyocytes: cellular architecture in health and disease

Mitochondrial dynamics and Mitochondrial autophagy: Molecular Structure, Orchestrating Mechanism and Related Disorders

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

Mitochondrial dysfunction: mechanisms and advances in therapy

Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease

The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics

Mitochondrial Dynamics, Diabetes, and Cardiovascular Disease

Potential indicators of mitochondrial structure and function.

Mitochondrial Dynamics in Adult Cardiomyocytes and Heart Diseases

The Role of Mitochondria in Cellular Toxicity As a Potential Drug Target

Mitochondrial Dysfunctions: Genetic and Cellular Implications Revealed by Various Model Organisms